{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Gina", "organization": "", "rank": 1, "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "news_desk": "National", "slideshow_credits": null, "abstract": null, "multimedia": [{"type": "image", "url": "images/2016/11/16/science/15HEART/15HEART-thumbWide.jpg", "legacy": {"wide": "images/2016/11/16/science/15HEART/15HEART-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "width": 190, "subtype": "wide", "height": 126}, {"type": "image", "url": "images/2016/11/16/science/15HEART/15HEART-articleLarge.jpg", "legacy": {"xlarge": "images/2016/11/16/science/15HEART/15HEART-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "width": 600, "subtype": "xlarge", "height": 400}, {"type": "image", "url": "images/2016/11/16/science/15HEART/15HEART-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/11/16/science/15HEART/15HEART-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "width": 75, "subtype": "thumbnail", "height": 75}], "headline": {"print_headline": "Study Shows Promise for Costly Cholesterol Drugs, but They Remain Hard to Obtain", "main": "Study Shows Promise for Expensive Cholesterol Drugs, but They Are Still Hard to Obtain"}, "print_page": "20", "keywords": [{"value": "Cholesterol", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Journal of the American Medical Assn", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Nissen, Steven E", "is_major": "N", "rank": "5", "name": "persons"}, {"value": "Heart", "is_major": "N", "rank": "7", "name": "subject"}, {"value": "Statins (Cholesterol-Lowering Drugs)", "is_major": "N", "rank": "8", "name": "subject"}], "snippet": "A study of so-called PCSK9 inhibitors showed they can reduce the size of plaques in arteries that may cause heart attacks, a signal that they will show benefit in reducing heart attack risk....", "source": "The New York Times", "lead_paragraph": "A study of so-called PCSK9 inhibitors showed they can reduce the size of plaques in arteries that may cause heart attacks, a signal that they will show benefit in reducing heart attack risk.", "word_count": "1113", "pub_date": "2016-11-15T16:46:37Z", "subsection_name": null, "blog": [], "type_of_material": "News", "section_name": "Health", "web_url": "http://www.nytimes.com/2016/11/16/health/cholesterol-drugs-pcsk9-inhibitors.html", "_id": "582b3bf37c459f6a5fcce1b3"}